Who it affects
- Department of Health and Human Services
- Lyme disease prize competition participants
H.R. 7482 · House bill · Introduced Feb. 11, 2026
The LymeX Authorization Act would allow the Department of Health and Human Services to run prize competitions for new ways to prevent, diagnose, and treat Lyme disease.
Loading…
These are patterns in public records, not proof that money changed a vote. The same rules apply to every member. How we decide
In committee
No recorded votes yet.
See each vote ↓No lobbying reported yet
Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.
Written with AI from the official summary by Congress's research office.
No recorded roll-call vote on this bill yet.
PAC, lobbyist campaign and qualifying employee money this election, shown separately and never added together. Lobbying reports name the bills a group worked on, not which side it took.
No lobbying reported yet. Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.
LymeX Authorization Act This bill authorizes the Department of Health and Human Services to carry out prize competitions to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease. Lyme disease is a bacterial infection carried by ticks that can spread to joints, the heart, and the nervous system.
Summary on Congress.gov ↗No lobbying report we have loaded names this bill. That doesn't mean no lobbying took place.
Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published. Reports for October through December 2026 are due January 20, 2027.